L D. Shultz, et.al., Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice., Journal of immunology (Baltimore, Md. : 1950), 1995, 154

http://rdf.ncbi.nlm.nih.gov/pubmed/7995938

L D. Shultz, et.al., Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice., Journal of immunology (Baltimore, Md. : 1950), 1995, 154

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased erythrocyte cell number in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004993
• increased T cell derived lymphoma incidence in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010472
• abnormal thymus lobule morphology in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005067
• decreased level of surface class I molecules in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017452
• homeostasis/metabolism phenotype in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1014999
• abnormal complement pathway in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002447
• immune system phenotype in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1020915
• impaired complement classical pathway in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002448
• abnormal complement pathway in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017462
• impaired natural killer cell mediated cytotoxicity in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002457
• decreased level of surface class I molecules in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005061
• decreased level of surface class I molecules in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002439
• abnormal thymus lobule morphology in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002537
• decreased level of surface class I molecules in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004980
• decreased NK cell number in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005085
• decreased bone marrow cell number in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002432
• abnormal lymph node morphology in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004984
• abnormal thymus lobule morphology in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017458
• decreased erythrocyte cell number in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002452
• increased length of allograft survival in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010474
• abnormal complement pathway in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005069
• increased mean corpuscular volume in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004990
• abnormal thymus corticomedullary boundary morphology in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017508
• increased mean corpuscular volume in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002449
• decreased level of surface class I molecules in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002531
• decreased NK cell number in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005004
• homeostasis/metabolism phenotype in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1018270
• decreased NK cell number in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002555
• abnormal thymus corticomedullary boundary morphology in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002560
• decreased bone marrow cell number in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002524
• increased mean corpuscular volume in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002541
• decreased bone marrow cell number in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005054
• immune system phenotype in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016057
• increased T cell derived lymphoma incidence in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010452
• increased T cell derived lymphoma incidence in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010603
• abnormal thymus lobule morphology in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004986
• abnormal complement pathway in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002539
• abnormal lymph node morphology in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002443
• immune system phenotype in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1020434
• hematopoietic system phenotype in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017626
• decreased NK cell number in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002463
• impaired natural killer cell mediated cytotoxicity in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017483
• impaired natural killer cell mediated cytotoxicity in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002549
• hematopoietic system phenotype in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1020435
• homeostasis/metabolism phenotype in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016060
• immune system phenotype in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017625
• increased T cell derived lymphoma incidence in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010586
• abnormal lymph node morphology in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005065
• abnormal thymus lobule morphology in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002445
• impaired complement classical pathway in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005070
• decreased NK cell number in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017495
• abnormal lymph node morphology in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017455
• increased mean corpuscular volume in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017464
• premature death in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010587
• impaired complement classical pathway in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002540
• decreased erythrocyte cell number in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002544
• premature death in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010473
• increased length of allograft survival in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010588
• impaired complement classical pathway in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017463
• increased length of allograft survival in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017472
• increased mean corpuscular volume in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005071
• hematopoietic system phenotype in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1020916
• abnormal thymus corticomedullary boundary morphology in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002468
• decreased erythrocyte cell number in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017466
• abnormal thymus corticomedullary boundary morphology in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005009
• impaired natural killer cell mediated cytotoxicity in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005079
• increased length of allograft survival in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010454
• increased length of allograft survival in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010605
• hematopoietic system phenotype in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1014997
• abnormal complement pathway in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004988
• muscle phenotype in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1020917
• decreased bone marrow cell number in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017439
• hematopoietic system phenotype in RBRC06336
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016058
• impaired complement classical pathway in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004989
• impaired natural killer cell mediated cytotoxicity in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004998
• homeostasis/metabolism phenotype in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1020918
• abnormal thymus corticomedullary boundary morphology in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005090
• premature death in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010453
• abnormal lymph node morphology in RBRC01346
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002535
• immune system phenotype in RBRC01300
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1014996
• premature death in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010604
• decreased erythrocyte cell number in RBRC02775
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005074
• decreased bone marrow cell number in RBRC02771
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004973

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased bone marrow cell number_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0000333NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• decreased pre-B cell number_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0008209NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• decreased B cell number_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0005017NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• abnormal thymus corticomedullary boundary morphology_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0009543NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• impaired complement classical pathway_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0002473NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• decreased NK cell number_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0008045NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• abnormal response to transplant_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0005671CB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• spleen hypoplasia_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0000694NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• increased T cell derived lymphoma incidence_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0002024NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• impaired natural killer cell mediated cytotoxicity_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0005070NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• decreased immunoglobulin level_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0002460CB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• increased mean corpuscular volume_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0002590NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• abnormal response to transplant_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0005671NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• decreased CD4-positive, alpha beta T cell number_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0008075NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• abnormal lymph node morphology_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0002339NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• increased length of allograft survival_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0004751NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• increased macrophage cell number_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0005425NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• decreased erythrocyte cell number_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0002875NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• decreased T cell number_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0005018NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• decreased level of surface class I molecules_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0001841NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• abnormal spleen white pulp morphology_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0002357NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• premature death_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0002083NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• abnormal complement pathway_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0002471B6CB17PrkdcscidSzPrkdcscidPrkdcscidPrkdcscid
• thymus cysts_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0014130NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• decreased immunoglobulin level_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0002460NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• decreased CD8-positive, alpha-beta T cell number_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0008079NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• decreased lymphocyte cell number_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0005016NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• increased length of allograft survival_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0004751CB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• increased granulocyte number_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0000322NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid
• abnormal thymus lobule morphology_Prkdc<scid>/Prkdc<scid>
  http://metadb.riken.jp/0002367NODCB17PrkdcscidPrkdcscidPrkdcscidPrkdcscid